1. Berneburg M, Trelles M, Friguet B, Ogden S, Esrefoglu M, Kaya G, et al. How best to halt and/or revert UV-induced skin ageing: strategies, facts and fiction. Exp Dermatol. 2008;17:228–40. [PubMed] [Google Scholar] 2. Makrantonaki E, Adjaye J, Herwig R, Brink TC, Groth D, Hultschig C, et al. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell. 2006;5:331–44. doi: 10.1111/j.1474-9726.2006.00223.x. [PubMed] [CrossRef] [Google Scholar] 3. Brincat MP. Hormone replacement therapy and the skin. Maturitas 2000; 35:107–117. 9 Makrantonaki E, Zouboulis CC. Androgens and aging of the skin. Curr Opin Endocrinol Diabetes Obes. 2009;16:240–5. [PubMed] [Google Scholar] 4. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138:1462–70. doi: 10.1001/archderm.138.11.1462. [PubMed] [CrossRef] [Google Scholar] 5. Chung JH, Kang S, Varani J, Lin J, Fisher GJ, Voorhees JJ. Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 2000;115:177–82. doi: 10.1046/j.1523-1747.2000.00009.x. [PubMed] [CrossRef] [Google Scholar] 6. Baumann L. Skin ageing and its treatment. J Pathol. 2007;211:241–51. doi: 10.1002/path.2098. [PubMed] [CrossRef] [Google Scholar] 7. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 2007;26:58–68. doi: 10.1016/j.matbio.2006.08.261. [PubMed] [CrossRef] [Google Scholar] 8. Soltés L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules. 2006;7:659–68. doi: 10.1021/bm050867v. [PubMed] [CrossRef] [Google Scholar] 9. Knudson CB, Knudson W. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin Orthop Relat Res. 2004;(Suppl):S152–62. doi: 10.1097/01.blo.0000143804.26638.82. [PubMed] [CrossRef] [Google Scholar] 10. Toole BP, Zoltan-Jones A, Misra S, Ghatak S. Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissues Organs. 2005;179:66–72. doi: 10.1159/000084510. [PubMed] [CrossRef] [Google Scholar] 11. Toole BP, Ghatak S, Misra S. Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol. 2008;9:249–52. doi: 10.2174/138920108785161569. [PubMed] [CrossRef] [Google Scholar] 12. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002;21:25–9. doi: 10.1016/S0945-053X(01)00184-6. [PubMed] [CrossRef] [Google Scholar] 13. Turino GM, Cantor JO. Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med. 2003;167:1169–75. doi: 10.1164/rccm.200205-449PP. [PubMed] [CrossRef] [Google Scholar] 14. Jackson DG. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev. 2009;230:216–31. doi: 10.1111/j.1600-065X.2009.00803.x. [PubMed] [CrossRef] [Google Scholar] 15. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91:221–64. doi: 10.1152/physrev.00052.2009. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 16. Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol. 2008;26:106–22. doi: 10.1016/j.clindermatol.2007.09.013. [PubMed] [CrossRef] [Google Scholar] 17. Weissmann B, Meyer K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc. 1954;76:1753–7. doi: 10.1021/ja01636a010. [CrossRef] [Google Scholar] 18. Weissmann B, Meyer K, Sampson P, Linker A. Isolation of oligosaccharides enzymatically produced from hyaluronic acid. J Biol Chem. 1954;208:417–29. [PubMed] [Google Scholar] 19. Scott JE, Heatley F. Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study. Proc Natl Acad Sci U S A. 1999;96:4850–5. doi: 10.1073/pnas.96.9.4850. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 20. Laurent TC. Structure of hyaluronic acid. In: Balazs, EA, ed. Chemistry and Molecular Biology of the Intercellular Matrix, Academic Press: New York, 1970:p. 703. [Google Scholar] 21. Bates EJ, Harper GS, Lowther DA, Preston BN. Effect of oxygen-derived reactive species on cartilage proteoglycan-hyaluronate aggregates. Biochem Int. 1984;8:629–37. [PubMed] [Google Scholar] 22. Lowther DA, Rogers HJ. Biosynthesis of hyaluronate. Nature. 1955;175:435. doi: 10.1038/175435a0. [PubMed] [CrossRef] [Google Scholar] 23. MacLennan AP. The production of capsules, hyaluronic acid and hyaluronidase by 25 strains of group C streptococci. J Gen Microbiol. 1956;15:485–91. doi: 10.1099/00221287-15-3-485. [PubMed] [CrossRef] [Google Scholar] 25. Juhlin L. Hyaluronan in skin. J Intern Med. 1997;242:61–6. doi: 10.1046/j.1365-2796.1997.00175.x. [PubMed] [CrossRef] [Google Scholar] 26. Tammi R, Ripellino JA, Margolis RU, Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol. 1988;90:412–4. doi: 10.1111/1523-1747.ep12456530. [PubMed] [CrossRef] [Google Scholar] 27. Armstrong SE, Bell DR. Relationship between lymph and tissue hyaluronan in skin and skeletal muscle. Am J Physiol Heart Circ Physiol. 2002;283:H2485–94. [PubMed] [Google Scholar] 28. Tzellos TG, Sinopidis X, Kyrgidis A, Vahtsevanos K, Triaridis S, Printza A, et al. Differential hyaluronan homeostasis and expression of proteoglycans in juvenile and adult human skin. J Dermatol Sci. 2011;61:69–72. doi: 10.1016/j.jdermsci.2010.10.010. [PubMed] [CrossRef] [Google Scholar] 29. Tzellos TG, Klagas I, Vahtsevanos K, Triaridis S, Printza A, Kyrgidis A, et al. Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol. 2009;18:1028–35. doi: 10.1111/j.1600-0625.2009.00889.x. [PubMed] [CrossRef] [Google Scholar] 30. Reed RK, Lilja K, Laurent TC. Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand. 1988;134:405–11. doi: 10.1111/j.1748-1716.1988.tb08508.x. [PubMed] [CrossRef] [Google Scholar] 31. Meyer K, Palmer JW. The Polysaccharide of the vitreous humor. J Biol Chem. 1934;107:629–34. [Google Scholar] 32. Hamerman D, Schuster H. Hyaluronate in normal human synovial fluid. J Clin Invest. 1958;37:57–64. doi: 10.1172/JCI103585. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 33. Ragan C, Meyer K. The hyaluronic acid of synovial fluid in rheumatoid arthritis. J Clin Invest. 1949;28:56–9. doi: 10.1172/JCI102053. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 34. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4:528–39. doi: 10.1038/nrc1391. [PubMed] [CrossRef] [Google Scholar] 35. Papakonstantinou E, Karakiulakis G, Roth M, Block LH. Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1995;92:9881–5. doi: 10.1073/pnas.92.21.9881. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 36. Papakonstantinou E, Roth M, Tamm M, Eickelberg O, Perruchoud AP, Karakiulakis G. Hypoxia differentially enhances the effects of transforming growth factor-beta isoforms on the synthesis and secretion of glycosaminoglycans by human lung fibroblasts. J Pharmacol Exp Ther. 2002;301:830–7. doi: 10.1124/jpet.301.3.830. [PubMed] [CrossRef] [Google Scholar] 37. Papakonstantinou E, Kouri FM, Karakiulakis G, Klagas I, Eickelberg O. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension. Eur Respir J. 2008;32:1504–12. doi: 10.1183/09031936.00159507. [PubMed] [CrossRef] [Google Scholar] 38. Klagas I, Goulet S, Karakiulakis G, Zhong J, Baraket M, Black JL, et al. Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J. 2009;34:616–28. doi: 10.1183/09031936.00070808. [PubMed] [CrossRef] [Google Scholar] 39. Papakonstantinou E, Karakiulakis G. The ‘sweet’ and ‘bitter’ involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol. 2009;157:1111–27. doi: 10.1111/j.1476-5381.2009.00279.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 40. Papakonstantinou E, Karakiulakis G, Eickelberg O, Perruchoud AP, Block LH, Roth M. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology. 1998;8:821–30. doi: 10.1093/glycob/8.8.821. [PubMed] [CrossRef] [Google Scholar] 41. Goulas A, Hatzichristou DG, Karakiulakis G, Mirtsou-Fidani V, Kalinderis A, Papakonstantinou E. Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution. Prostate. 2000;44:104–10. doi: 10.1002/1097-0045(20000701)44:2<104::AID-PROS2>3.0.CO;2-6. [PubMed] [CrossRef] [Google Scholar] 42. Goulas A, Papakonstantinou E, Karakiulakis G, Mirtsou-Fidani V, Kalinderis A, Hatzichristou DG. Tissue structure-specific distribution of glycosaminoglycans in the human penis. Int J Biochem Cell Biol. 2000;32:975–82. doi: 10.1016/S1357-2725(00)00038-8. [PubMed] [CrossRef] [Google Scholar] 43. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol. 2000;12:581–6. doi: 10.1016/S0955-0674(00)00135-6. [PubMed] [CrossRef] [Google Scholar] 44. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol. 1986;119:219–34. doi: 10.1016/S0022-5193(86)80076-5. [PubMed] [CrossRef] [Google Scholar] 45. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem. 2002;277:41046–59. doi: 10.1074/jbc.M109443200. [PubMed] [CrossRef] [Google Scholar] 46. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996;98:2403–13. doi: 10.1172/JCI119054. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 47. Horton MR, McKee CM, Bao C, Liao F, Farber JM, Hodge-DuFour J, et al. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem. 1998;273:35088–94. doi: 10.1074/jbc.273.52.35088. [PubMed] [CrossRef] [Google Scholar] 48. Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell. 2004;13:483–96. doi: 10.1016/S1097-2765(04)00080-2. [PubMed] [CrossRef] [Google Scholar] 49. Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, Senga T, et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A. 2002;99:3609–14. doi: 10.1073/pnas.052026799. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 50. Bai KJ, Spicer AP, Mascarenhas MM, Yu L, Ochoa CD, Garg HG, et al. The role of hyaluronan synthase 3 in ventilator-induced lung injury. Am J Respir Crit Care Med. 2005;172:92–8. doi: 10.1164/rccm.200405-652OC. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 51. Beck-Schimmer B, Oertli B, Pasch T, Wüthrich RP. Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol. 1998;9:2283–90. [PubMed] [Google Scholar] 52. Zoltan-Jones A, Huang L, Ghatak S, Toole BP. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem. 2003;278:45801–10. doi: 10.1074/jbc.M308168200. [PubMed] [CrossRef] [Google Scholar] 53. Jameson JM, Cauvi G, Sharp LL, Witherden DA, Havran WL. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J Exp Med. 2005;201:1269–79. doi: 10.1084/jem.20042057. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 54. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11:1173–9. doi: 10.1038/nm1315. [PubMed] [CrossRef] [Google Scholar] 55. Jiang D, Liang J, Li Y, Noble PW. The role of Toll-like receptors in non-infectious lung injury. Cell Res. 2006;16:693–701. doi: 10.1038/sj.cr.7310085. [PubMed] [CrossRef] [Google Scholar] 56. Li L, Heldin CH, Heldin P. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem. 2006;281:26512–9. doi: 10.1074/jbc.M605607200. [PubMed] [CrossRef] [Google Scholar] 57. Turley EA. The role of a cell-associated hyaluronan-binding protein in fibroblast behaviour. Ciba Found Symp. 1989;143:121–33, discussion 133-7, 281-5. [PubMed] [Google Scholar] 58. Knudson W. Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol. 1996;148:1721–6. [PMC free article] [PubMed] [Google Scholar] 59. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995;55:428–33. [PubMed] [Google Scholar] 60. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228:1324–6. doi: 10.1126/science.2408340. [PubMed] [CrossRef] [Google Scholar] 61. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem. 1997;272:8013–8. doi: 10.1074/jbc.272.12.8013. [PubMed] [CrossRef] [Google Scholar] 62. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol. 2000;165:1863–70. [PubMed] [Google Scholar] 63. Papakonstantinou E, Klagas I, Karakiulakis G, Hostettler K, S’ng CT, Kotoula V, et al. Steroids and β2 Agonists Regulate Hyaluronan Metabolism in Asthma Airway Smooth Muscle Cells. Am J Respir Cell Mol Biol. 2012 doi: 10.1165/rcmb.2012-0101OC. In press. [PubMed] [CrossRef] [Google Scholar] 65. Watanabe K, Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase. J Biol Chem. 1996;271:22945–8. doi: 10.1074/jbc.271.38.22945. [PubMed] [CrossRef] [Google Scholar] 66. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem. 1997;272:13997–4000. doi: 10.1074/jbc.272.22.13997. [PubMed] [CrossRef] [Google Scholar] 67. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999;274:25085–92. doi: 10.1074/jbc.274.35.25085. [PubMed] [CrossRef] [Google Scholar] 68. Itano N, Kimata K. Mammalian hyaluronan synthases. IUBMB Life. 2002;54:195–9. doi: 10.1080/15216540214929. [PubMed] [CrossRef] [Google Scholar] 69. Fraser JR, Laurent TC, Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J. 1981;200:415–24. [PMC free article] [PubMed] [Google Scholar] 70. Reed RK, Laurent UB, Fraser JR, Laurent TC. Removal rate of [3H]hyaluronan injected subcutaneously in rabbits. Am J Physiol. 1990;259:H532–5. [PubMed] [Google Scholar] 71. Laurent UB, Dahl LB, Reed RK. Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver. Exp Physiol. 1991;76:695–703. [PubMed] [Google Scholar] 72. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106:818–39. doi: 10.1021/cr050247k. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 74. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001;20:499–508. doi: 10.1016/S0945-053X(01)00172-X. [PubMed] [CrossRef] [Google Scholar] 75. Frost GI, Stern R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal Biochem. 1997;251:263–9. doi: 10.1006/abio.1997.2262. [PubMed] [CrossRef] [Google Scholar] 76. Guntenhöner MW, Pogrel MA, Stern R. A substrate-gel assay for hyaluronidase activity. Matrix. 1992;12:388–96. doi: 10.1016/S0934-8832(11)80035-1. [PubMed] [CrossRef] [Google Scholar] 77. Chichibu K, Matsuura T, Shichijo S, Yokoyama MM. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta. 1989;181:317–23. doi: 10.1016/0009-8981(89)90237-4. [PubMed] [CrossRef] [Google Scholar] 78. Natowicz MR, Short MP, Wang Y, Dickersin GR, Gebhardt MC, Rosenthal DI, et al. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med. 1996;335:1029–33. doi: 10.1056/NEJM199610033351405. [PubMed] [CrossRef] [Google Scholar] 79. Lepperdinger G, Strobl B, Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem. 1998;273:22466–70. doi: 10.1074/jbc.273.35.22466. [PubMed] [CrossRef] [Google Scholar] 80. Hemming R, Martin DC, Slominski E, Nagy JI, Halayko AJ, Pind S, et al. Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells. Glycobiology. 2008;18:280–9. doi: 10.1093/glycob/cwn006. [PubMed] [CrossRef] [Google Scholar] 81. Lapcík L, Jr., Chabrecek P, Stasko A. Photodegradation of hyaluronic acid: EPR and size exclusion chromatography study. Biopolymers. 1991;31:1429–35. doi: 10.1002/bip.360311209. [PubMed] [CrossRef] [Google Scholar] 82. Laurent TC. The chemistry, biology, and medical applications of hyaluronan and its derivatives. London: Portland Press; 1998:621. [Google Scholar] 83. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol. 1990;2:839–44. doi: 10.1016/0955-0674(90)90081-O. [PubMed] [CrossRef] [Google Scholar] 84. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 1993;7:1233–41. [PubMed] [Google Scholar] 85. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev. 1992;11:21–30. doi: 10.1007/BF00047600. [PubMed] [CrossRef] [Google Scholar] 86. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol. 1992;117:1343–50. doi: 10.1083/jcb.117.6.1343. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 87. Yang B, Zhang L, Turley EA. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem. 1993;268:8617–23. [PubMed] [Google Scholar] 88. Lokeshwar VB, Selzer MG. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem. 2000;275:27641–9. [PubMed] [Google Scholar] 89. Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med. 1996;183:1663–8. doi: 10.1084/jem.183.4.1663. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 90. Samuel SK, Hurta RA, Spearman MA, Wright JA, Turley EA, Greenberg AH. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol. 1993;123:749–58. doi: 10.1083/jcb.123.3.749. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 91. Ripellino JA, Bailo M, Margolis RU, Margolis RK. Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum. J Cell Biol. 1988;106:845–55. doi: 10.1083/jcb.106.3.845. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 92. Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994;102:385–9. doi: 10.1111/1523-1747.ep12371800. [PubMed] [CrossRef] [Google Scholar] 93. Wang C, Tammi M, Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry. 1992;98:105–12. doi: 10.1007/BF00717001. [PubMed] [CrossRef] [Google Scholar] 94. Bertheim U, Hellström S. The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars. Br J Plast Surg. 1994;47:483–9. doi: 10.1016/0007-1226(94)90031-0. [PubMed] [CrossRef] [Google Scholar] 95. DePalma RL, Krummel TM, Durham LA, 3rd, Michna BA, Thomas BL, Nelson JM, et al. Characterization and quantitation of wound matrix in the fetal rabbit. Matrix. 1989;9:224–31. doi: 10.1016/S0934-8832(89)80054-X. [PubMed] [CrossRef] [Google Scholar] 96. Mast BA, Flood LC, Haynes JH, DePalma RL, Cohen IK, Diegelmann RF, et al. Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Matrix. 1991;11:63–8. doi: 10.1016/S0934-8832(11)80228-3. [PubMed] [CrossRef] [Google Scholar] 97. Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR, Stern R. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg. 1991;213:292–6. doi: 10.1097/00000658-199104000-00003. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 98. Stuhlmeier KM, Pollaschek C. Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation. J Biol Chem. 2004;279:8753–60. doi: 10.1074/jbc.M303945200. [PubMed] [CrossRef] [Google Scholar] 99. Karvinen S, Pasonen-Seppänen S, Hyttinen JM, Pienimäki JP, Törrönen K, Jokela TA, et al. Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J Biol Chem. 2003;278:49495–504. doi: 10.1074/jbc.M310445200. [PubMed] [CrossRef] [Google Scholar] 100. Wilkinson TS, Potter-Perigo S, Tsoi C, Altman LC, Wight TN. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol. 2004;31:92–9. doi: 10.1165/rcmb.2003-0380OC. [PubMed] [CrossRef] [Google Scholar] 101. Pienimaki JP, Rilla K, Fulop C, Sironen RK, Karvinen S, Pasonen S, et al. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J Biol Chem. 2001;276:20428–35. doi: 10.1074/jbc.M007601200. [PubMed] [CrossRef] [Google Scholar] 102. Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int. 2000;58:1953–62. doi: 10.1111/j.1523-1755.2000.00367.x. [PubMed] [CrossRef] [Google Scholar] 103. Li Y, Rahmanian M, Widström C, Lepperdinger G, Frost GI, Heldin P. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am J Respir Cell Mol Biol. 2000;23:411–8. [PubMed] [Google Scholar] 104. Tammi R, Pasonen-Seppänen S, Kolehmainen E, Tammi M. Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J Invest Dermatol. 2005;124:898–905. doi: 10.1111/j.0022-202X.2005.23697.x. [PubMed] [CrossRef] [Google Scholar] 105. Tzellos TG, Dionyssopoulos A, Klagas I, Karakiulakis G, Lazaridis L, Papakonstantinou E. Differential glycosaminoglycan expression and hyaluronan homeostasis in juvenile hyaline fibromatosis. J Am Acad Dermatol. 2009;61:629–38. doi: 10.1016/j.jaad.2009.03.042. [PubMed] [CrossRef] [Google Scholar] 106. Weiss JM, Sleeman J, Renkl AC, Dittmar H, Termeer CC, Taxis S, et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol. 1997;137:1137–47. doi: 10.1083/jcb.137.5.1137. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 107. Weiss JM, Renkl AC, Sleeman J, Dittmar H, Termeer CC, Taxis S, et al. CD44 variant isoforms are essential for the function of epidermal Langerhans cells and dendritic cells. Cell Adhes Commun. 1998;6:157–60. doi: 10.3109/15419069809004472. [PubMed] [CrossRef] [Google Scholar] 108. Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell. 1995;82:19–26. doi: 10.1016/0092-8674(95)90048-9. [PubMed] [CrossRef] [Google Scholar] 109. Longas MO, Russell CS, He XY. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res. 1987;159:127–36. doi: 10.1016/S0008-6215(00)90010-7. [PubMed] [CrossRef] [Google Scholar] 110. Gilchrest BA. A review of skin ageing and its medical therapy. Br J Dermatol. 1996;135:867–75. doi: 10.1046/j.1365-2133.1996.d01-1088.x. [PubMed] [CrossRef] [Google Scholar] 111. Bernstein EF, Underhill CB, Hahn PJ, Brown DB, Uitto J. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol. 1996;135:255–62. doi: 10.1111/j.1365-2133.1996.tb01156.x. [PubMed] [CrossRef] [Google Scholar] 112. Uitto J. Understanding premature skin aging. N Engl J Med. 1997;337:1463–5. doi: 10.1056/NEJM199711133372011. [PubMed] [CrossRef] [Google Scholar] 113. Röck K, Grandoch M, Majora M, Krutmann J, Fischer JW. Collagen fragments inhibit hyaluronan synthesis in skin fibroblasts in response to ultraviolet B (UVB): new insights into mechanisms of matrix remodeling. J Biol Chem. 2011;286:18268–76. doi: 10.1074/jbc.M110.201665. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 114. Oh JH, Kim YK, Jung JY, Shin JE, Chung JH. Changes in glycosaminoglycans and related proteoglycans in intrinsically aged human skin in vivo. Exp Dermatol. 2011;20:454–6. doi: 10.1111/j.1600-0625.2011.01258.x. [PubMed] [CrossRef] [Google Scholar] |
